Back to Products
Characterised Reference Standards & Nitrosamines

Pharmaceutical Impurity Reference Standards Supplier

High-purity API impurities, mutagenic and nitroso reference standards, and characterised compounds supplied with comprehensive analytical data packages (CoA, NMR, MASS, HPLC) from PEC Pharma.

Live Reference Standards Catalog

Search Pharmaceutical Impurity Standards

Showing 20 of 20 characterised impurity standards with COA, NMR, LC-MS & HPLC analytical data.

⚡ 24–48h Dispatch on In-Stock Items
🔍
Impurity Standard & ParentCAS NumberClassificationMolecular Formula / PurityAnalytical PackageAction
Silodosin Related Compound AParent Drug: Silodosin239103-62-7Related Substance
C25H32F3N3O4
≥ 98.0% (HPLC)
CoA1H-NMR13C-NMRMASS / LC-MSHPLC PurityIR
Silodosin Related Compound BParent Drug: Silodosin160970-64-9Process Impurity
C25H30F3N3O3
≥ 95.0% (HPLC)
CoA1H-NMRMASSHPLC Purity
Silodosin Related Compound CParent Drug: Silodosin160970-55-8Related Substance
C24H30F3N3O4
≥ 97.5% (HPLC)
CoA1H-NMR13C-NMRMASSHPLC Purity
Silodosin Related Compound DParent Drug: Silodosin175135-26-9Process Impurity
C14H19NO3
≥ 98.5% (HPLC)
CoA1H-NMRMASSHPLC Purity
Descarbamoyl SilodosinParent Drug: Silodosin160970-65-0Degradation Product
C24H31F3N2O3
≥ 95.0% (HPLC)
CoA1H-NMRMASSHPLC
Lacosamide Related Compound AParent Drug: Lacosamide175481-37-5Related Substance
C12H16N2O3
≥ 98.0% (HPLC)
CoA1H-NMR13C-NMRMASSHPLC PurityChiral Purity
Lacosamide Related Compound BParent Drug: Lacosamide175481-38-6Process Impurity
C14H20N2O4
≥ 97.0% (HPLC)
CoA1H-NMRMASSHPLC
O-Desmethyl LacosamideParent Drug: Lacosamide175481-40-0Related Substance
C12H16N2O3
≥ 96.5% (HPLC)
CoA1H-NMRMASSHPLC Purity
Bupropion Related Compound AParent Drug: Bupropion HCl92211-19-9Related Substance
C13H16ClNO
≥ 98.0% (HPLC)
CoA1H-NMR13C-NMRMASSHPLC Purity
Bupropion Related Compound BParent Drug: Bupropion HCl1049718-72-0Process Impurity
C13H18ClNO
≥ 95.0% (HPLC)
CoA1H-NMRMASSHPLC Purity
Bupropion Related Compound CParent Drug: Bupropion HCl839572-92-6Related Substance
C13H18ClNO
≥ 97.0% (HPLC)
CoA1H-NMRMASSHPLC Purity
3-Chlorobenzoic AcidParent Drug: Bupropion HCl535-80-8Degradation Product
C7H5ClO2
≥ 99.0% (GC/HPLC)
CoA1H-NMRGC-MSAssay
Oxymetazoline Related Compound AParent Drug: Oxymetazoline HCl5579-92-0Related Substance
C16H22N2O
≥ 98.0% (HPLC)
CoA1H-NMRMASSHPLC Purity
Xylometazoline Impurity AParent Drug: Xylometazoline HCl21409-26-7Related Substance
C16H22N2
≥ 97.5% (HPLC)
CoA1H-NMRMASSHPLC Purity
Homotaurine (Acamprosate Related Compound)Parent Drug: Acamprosate Calcium3687-18-1Process Impurity
C3H9NO3S
≥ 98.5% (HPLC)
CoA1H-NMR13C-NMRMASSHPLC Purity
Omeprazole Related Compound A (Omeprazole Sulfone)Parent Drug: Omeprazole88546-55-8Degradation Product
C17H19N3O4S
≥ 98.0% (HPLC)
CoA1H-NMRMASSHPLC Purity
N-Nitrosodimethylamine (NDMA) Reference StandardParent Drug: Nitrosamines (ICH M7)62-75-9Nitrosamine / Genotoxic
C2H6N2O
≥ 99.0% (GC-MS / NMR)
CoA1H-NMRGC-MS HeadspaceQuantitative Assay
N-Nitrosodiethylamine (NDEA) Reference StandardParent Drug: Nitrosamines (ICH M7)55-18-5Nitrosamine / Genotoxic
C4H10N2O
≥ 98.5% (GC-MS / NMR)
CoA1H-NMRGC-MSQuantitative Assay
N-Nitroso-N-methyl-4-aminobutyric acid (NMBA)Parent Drug: Nitrosamines (ICH M7)61445-55-4Nitrosamine / Genotoxic
C5H10N2O3
≥ 98.0% (LC-MS / NMR)
CoA1H-NMRLC-MS/MSAssay
N-Nitrosodiisopropylamine (NDIPA)Parent Drug: Nitrosamines (ICH M7)601-77-4Nitrosamine / Genotoxic
C6H14N2O
≥ 98.0% (GC-MS / NMR)
CoA1H-NMRGC-MSAssay

Pharmaceutical Impurity Standards Overview

Pharmaceutical impurities and reference standards are essential tools for drug substance and drug product release testing, method validation and regulatory compliance. PEC Pharma supplies high-quality API impurities, nitroso impurities, in-house working standards and custom-synthesised molecules to support global drug manufacturers in releasing products with confidence.

Based in Vadodara, Gujarat, PEC Pharma Standards is positioned as a trusted source for characterised impurity materials with comprehensive analytical supporting data. Our portfolio is designed to help quality assurance and analytical development teams meet evolving pharmacopoeial and regulatory expectations without compromising on data integrity.

We adapt to changing regulations, customer demands and technological innovations that challenge the pharmaceutical industry. Every product is supplied with the analytical documentation required for identification, qualification and routine use in HPLC, GC and related chromatographic methods.

Impurity Reference Standard Applications

  • API release and stability testing — impurity reference standards for routine QC
  • Method development and validation — characterised materials for specificity and linearity studies
  • Nitroso impurity profiling — dedicated standards for emerging regulatory requirements
  • Genotoxic impurity assessment and control strategy support
  • Forced degradation and photostability studies requiring authentic impurity markers
  • Pharmacopoeial compliance testing for related substances and known impurities
  • Custom synthesis of project-specific impurities not available from catalog suppliers

Why Buy Impurity Standards from PEC Pharma

  • Comprehensive analytical package with every shipment — CoA, NMR, HPLC/GC, IR and more
  • Nitroso impurity expertise aligned to current industry regulatory focus
  • Custom synthesis capability for project-specific impurity targets
  • In-house working standards for consistent internal laboratory qualification
  • Vadodara-based manufacturing and supply with responsive commercial support
  • Integrated relationship with PEC Pharma's broader API and CDMO capabilities

How Impurity Standards Are Made

Impurity standards are synthesised using routes designed to produce material with defined chemical purity and a fully characterised structure. Synthesis strategies prioritise isolation of the target impurity or its closest structural equivalent for use as a reference standard in analytical methods.

Each batch undergoes structural confirmation and purity assessment through a suite of analytical techniques. PEC Pharma's quality-controlled laboratory infrastructure supports the data package required for customer method qualification and regulatory submissions.

For nitroso and genotoxic impurity classes, dedicated synthetic and analytical approaches are applied to meet the sensitivity and trace-level detection requirements of modern pharmaceutical quality standards.

Who Uses Impurity Reference Standards

  • API manufacturers requiring impurity standards for dossier and commercial release testing
  • Finished dosage formulators validating related substance methods
  • Analytical contract laboratories supporting pharma QC programmes
  • Regulatory affairs teams preparing impurity qualification documentation
  • Generic companies filing ANDA and country-specific submissions
  • International pharma companies sourcing standards from India-based suppliers

Impurity Standard Specifications

Each impurity standard is supplied with a documented analytical data package. Specifications are confirmed per product at enquiry stage.

  • Certificate of Analysis (CoA) with every batch
  • NMR (including C13) structural confirmation
  • Mass spectrometry identity data
  • HPLC/GC purity and assay determination
  • IR spectroscopy
  • TGA thermal analysis where applicable
  • Additional characterisation available on request

Impurity Standard Packaging

Impurities and reference standards are packed in containers appropriate to chemical stability and customer usage patterns. Cold-chain or light-protected packaging is applied where material sensitivity requires it.

Small-quantity vials for laboratory use and larger packs for method validation campaigns are available. Discuss your usage pattern and storage requirements when requesting a quotation.

Analytical Supporting Data

We supply our wide range of products to our clients with all required analytical supporting data:

CoANMRC13MASSHPLC/GCIRTGAetc.

Frequently Asked Questions

What types of impurity standards does PEC Pharma supply?

We supply API impurities, nitroso impurities, in-house working standards, genotoxic impurities and custom-synthesised molecules. Each product is accompanied by analytical supporting data including CoA, NMR, HPLC/GC and more.

What analytical data is included with impurity standards?

Our standard analytical package includes CoA, NMR, C13, mass spectrometry, HPLC/GC, IR and TGA where applicable. Additional characterisation can be arranged on request.

Can PEC Pharma synthesise custom impurities not in your catalog?

Yes. We offer custom synthesis of project-specific impurity targets. Provide the chemical structure, required quantity and purity specification for a feasibility assessment and quotation.

Do you supply nitroso impurity reference standards?

Yes. Nitroso impurity standards are a core part of our portfolio, supporting customers addressing current regulatory expectations for N-nitrosamine control in pharmaceutical products.

How do I place an enquiry for impurity standards?

Contact us via the enquiry form or email info@pecpharma.in with the impurity name or structure, quantity required and intended analytical application. Our team will confirm availability and lead time.

Related Products & Pages